2nd Global COVID- 19 Summit Commitments

The second Global COVID-19 Summit convened over partners and organizations from around the world to accelerate collective efforts to get shots into arms, enhance access to tests and treatments, protect the health workforce, and finance and build health security for future pandemics and other health crises.

The Summit garnered new financial commitments totaling more than $3 billion in new funding, not yet announced, above and beyond pledges made to date in 2022. This includes over $2 billion for immediate COVID-19 response and $962 million in commitments toward a new pandemic preparedness and global health security fund at the World Bank.

Commitments^[1] from Government, Other Partners, and Entities

Note: Country text is being validated with host governments and is not yet final.

• African Union: Will expand and continue its Saving Lives and Livelihoods Program to purchase COVID-19 vaccines for the African people, support the delivery of the vaccines, and support vaccination rollout programs at country level and increase vaccine manufacturing in Africa in partnership with Africa CDC and the Mastercard Foundation and other partners. Will also, through coordination by Africa CDC, strengthen public health institutions, increase local capacity for producing medical products, strengthen the health workforce, and establish action-oriented partnerships through its New Public Health Order Program.

• Australia: Pledged additional AUD $85 million in 2022 to COVAX and has delivered on the first half of its commitment made at the first Global COVID-19 Summit, to share 60 million vaccine doses by the end of 2022. Announced a AUD 375 million second phase for the Health Security Initiative for the Indo-Pacific region as well as committed AUD 100 million to the Coalition for Epidemic Preparedness Innovations.

• Austria: In 2022, committed to provide EUR 1.6 million annually to CEPI from 2022-2024 for a total of EUR 4.8 million. Delivering up to 14 million vaccine doses by mid-2022. Committed to remain active in donating vaccines and providing financial support and emergency assistance.

• Belgium: Will provide an additional EUR 15 million for COVID-19 vaccination efforts, including EUR 10 million for the ancillary costs needed for vaccine delivery and EUR 5 million for COVAX.

• Belize: Will accelerate efforts to vaccinate 70% of the population by September 2022 and promote boosters for at risk populations. Will support an extensive public education campaign to overcome vaccine hesitancy. Will construct a BZE1 6.8 million hospital to better serve community health needs and to expand and provide an additional BZE 3.2 million to the National Health Insurance Program.

• Canada: Will provide CAD 732 million in funding for the Access to COVID-19 Tools-Accelerator (ACT-A), enabling Canada to meet its fair share for the 2021-2022 ACT-A budget cycle, assessed at CAD 747 million. This funding includes a previous allocation of CAD 220 million to the COVAX Advance Market Commitment (AMC), announced by the Prime Minister on April 8, 2022 at the Gavi COVAX AMC Summit, and builds on the CAD 15 million announced by the Prime Minister on October 30, 2021, in support of COVAX Manufacturing Task Force partners. Canada is contributing to the international pandemic response and will continue to work with partners to ensure that we strengthen our collective ability to prevent, prepare and respond to disease outbreaks going forward.

• Belize: Will accelerate efforts to vaccinate 70% of the population by September 2022 and promote boosters for at risk populations. Will support an extensive public education campaign to overcome vaccine hesitancy. Will construct a $16.8 million hospital to better serve community health needs and to expand and provide an additional BZE 3.2 million to the National Health Insurance Program.

• Botswana: Commits to vaccinate at least 80 percent of its population according to the Country's National Vaccine Deployment plan, implementing the second stage of Phase 4 (5-12-year-olds) by mid-2022 pending successful consultation. Commits to sharing lessons learned on its success with other countries to help them reach Botswana's levels of vaccination success , the third highest vaccination rate in Africa. Will continue to focus on improving and accelerating vaccine uptake and coverage. Commits to setting policy to offer and avail free treatment to all people who are infected with COVID-19, have mild to moderate as well as severe illness, or are at risk for death due to risk factors, with treatment modalities are based on Botswana's updated treatment guidelines. Commits to manufacturing COVID-19 vaccines to improve local and regional equitable vaccines supply chain by the end of 2022, drawing lessons from the global demand-supply mismatch and non-equitable distribution of vaccines.

• Colombia: Will continue to vaccinate the 2 million Venezuelan migrants in Colombia and other historically excluded populations. Will share lessons on vaccinating populations from government partnerships with the private sector. Will provide technical assistance for mass vaccination campaigns, to improve supply chain logistics, and for surveillance of possible adverse events related to vaccination. Will also contribute to the discussions within the WHO on ways to strengthen prevention, preparedness, and response to pandemics. Will increase the number of migrants registered in the social security system from 400,000 to 900,000 in 2022.

• Côte D'Ivoire: Will increase vaccine demand creation and uptake, and accelerate vaccine coverage while immediately prioritizing fully vaccinating and providing boosters to key sub-populations such as teachers, healthcare workers, people with comorbidities, and adolescents. Will strengthen genomic sequencing to identify new variants. Will expand and sustain health system capacity and financing; increase domestic health budgets; and improve funds disbursement to enable timely salary, incentive, and other supportive payments for health care workers. Committed to continue promoting the One Health approach and strengthening the national One Health platform.

• Denmark: Will provide over USD 10 million for vaccine rollout via ACT-A (COVAX). Minister Møller Mortensen expressed support for strengthening WHO and support for WHO agreement on pandemic preparedness, prevention, and response.

• European Union: Will provide 300 million euro for vaccination support. Will provide 100 million euro for other ACT-A pillars. Will provide $450 million USD for the pandemic preparedness and global health security financial intermediary fund at the World Bank.

• France: Will provide EUR 220 M: 100 million euros to COVAX, 50 million euros to ACT-A, and 70 million euros to strengthen vaccine production capacity in developing countries, including Rwanda, Senegal, and South Africa.

• Germany: Will contribute EUR 50 million toward the establishment of a new global health security and pandemic preparedness fund housed at the World Bank. Committed EUR 1.1 billion to ACT-A's 2021/2022 replenishment cycle earlier in 2022 and an additional EUR 224 million for bilateral projects to help increase vaccine uptake. Part of Germany's overall contribution are EUR 850 million targeted support for vaccine logistics and strengthening of absorption capacities, especially in African countries ("LastMile Initiative") bilaterally and multilaterally through ACT-A. All contributions are subject to parliamentary approval.

• India: Will continue to extend boosters coverage to eligible populations and expand vaccinations to those under age 18, and continue working towards complete vaccination coverage for India's adult population. With the increased funding allocated for the 2022-2023 domestic health budget, will provide insurance coverage for healthcare workers, increase the number of health and wellness centers. Will increase the number of integrated public health and regional disease control laboratories, as well as bio-safety labs. Is increasing zoonotic surveillance, and will continue to supply vaccines and work on extending a SARS -CoV2 genomic consortium to neighboring countries.

• Indonesia: Will provide $5 million to CEPI for the period of 2022-2026, adding to the $1 million contribution made in 2020. Will continue accelerating vaccination efforts to achieve the WHO vaccination goal of the 70% population, including for the 189 million people of Indonesia by June 2022, while ensuring equitable access to vaccines across income and age groups, and those most at risk. Earmarked Rp122,54 trillion of the 2022 national budget to continue vaccination efforts, care for COVID-19 patients, provide health worker and tax incentives, and support local governments. As Co-Chair of COVAX AMC EG, commits to contribute to the global effort to ensure equitable access to vaccines and getting shots in arms, and to increase local and regional vaccine production capacity and research capability, including for vaccines beyond COVID-19 pandemic, including through the use of WHO mRNA technology hubs. In the framework of ACT-A, will continue to accelerate global equitable access to vaccines, therapeutics, diagnostics, and PPE through its roles as Co-Chair of the Tracking and Accelerating Progress Working Group and as Member of the Facilitation Council, the Financial and Resource Mobilization Working Group, and the Vaccine Manufacturing Working Group. As G20 President, supports the establishment of a new financing facility to ensure adequate and sustained financing for pandemic prevention, preparedness and response, with a central coordinating role of the WHO, and supported by the World Bank and in close cooperation with international partners. Commits to strengthen the central role of WHO in coordinating global health actions through leadership in the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies together with the United States. Through multilateral cooperation , seeks political and financial support for developing countries, including as Co-Host of COVAX AMC Summit and Second Global COVID-19 Summit, and ACT-A diplomatic outreach with likeminded partners.

• Italy: Will provide an additional 200 million euros to the ACT Accelerator, as well as31 million additional vaccine doses via COVAX.

• Japan: Will contribute up to $500 million to COVAX and expand the scope of the Last One Mile Support of additional $30 million US dollars to 17 new Latin American and the Caribbean and African countries. Pledges to contribute $300 million to CEPI. Will provide assistance of up to $200 million USD through JICA to enhance local production capacity for pharmaceutical and medical products including vaccines in Africa. Total contributions increase from $3.9 billion USD announced at the first Summit to $5 billion USD.

• Lichtenstein: Provided CHF 300,000 to COVAX in 2022.

• Nepal: Will accelerate vaccine coverage and immediately prioritize fully vaccinating and providing boosters to at-risk populations. Will provide a detailed plan and targets at the national and sub-national level for getting shots into arms and overcoming key barriers for at-risk populations, and will track and report on full vaccination and booster rates by key subgroups. Will designate a "high-level leader" to coordinate with donors, multinational development banks, and the COVID-19 vaccine delivery partnership. Will also develop a national and community level strategy to expand access to testing and prompt treatment, focusing on those at highest risk and integrating COVID-19 testing /treatment with existing health systems, and will update relevant testing and treatment guidelines. Will improve and expand community access to testing and treatments and pharmacovigilance programs. Will support health and frontline workers by providing PPE and water, sanitation, and hygiene access, and training.

• New Zealand: Will provide NZD 2.25 million to UNICEF to fund COVID-19 diagnostics in Vietnam and to maintain essential health services in the Philippines, and NZD 8 million to the Global Fund's COVID-19 Response Mechanism for lifesaving tests, treatments and personal protective equipment. Will continue its support in the Pacific region to enable access to and uptake of vaccines within comprehensive public health responses to the COVID-19 pandemic, as well as continuing its support for health security and health systems strengthening.

• Nigeria: Will support vaccination efforts for 112 million citizens above age 18 towards a vaccination goal of 70% of the population being vaccinated by December 2022. Will expand access to COVID 19 testing and treatment, focusing on those at highest risk, and will integrate testing/treatment into existing health systems while prioritizing COVID-19 for monthly reporting on the Integrated Disease Surveillance and Reporting system platform. Will train an additional 10,000 frontline healthcare workers by December 2022 on basic infection prevention and control measures, ensuring availability of oxygen, and eliminate stock-outs of PPE. Will strengthen laboratory capacity for genomic sequencing and specimen bio-banking for both diagnostics and surveillance activities, and will implement a national bio-bank policy. Will designate highest-level leadership to coordinate relevant government sectors to achieve these goals, in collaboration with the international community and its development partners, and will progressively increase domestic health budgets. Will promote businesses in Nigeria to integrate health security into organizational policies and business goals.

• Norway: Provided USD 222 million to the 2021/2022 budget cycle of ACT- A. Supports establishing a global health security and pandemic preparedness fund housed at the World Bank.

• Pakistan: Will accelerate vaccine coverage from 82 percent to 90 percent and provide boosters to eligible and at-risk populations, including school-aged children eligible for vaccines (age 12-18), by summer 2022. Plans to launch a second iteration of its robust national vaccination campaign in late May, striving to vaccinate hard-to-reach populations.

• Palau: Will maintain a proactive and robust response to the ongoing pandemic, maintain and enhance existing services and plans including non-COVID essential services, and will strengthen social protection programs for the vulnerable and affected population.

• Republic of Korea: Will provide $300 million USD for ACT-A over 3 years, from 2023-2025. This builds on the $100 million USD committed earlier in 2022 to COVAX. Express political support for the pandemic preparedness and global health security financial intermediary fund at the World Bank.

• Rwanda: Will vaccinate five- to eleven-year-old children with at least one dose by the end of 2022 and will vaccinate at least seventy percent of the total population with the primary series (two shots) by June 2022. Will double booster coverage from thirty percent to sixty percent of those eligible, and will continue to expand the Government of Rwanda's capacity to locally manufacture vaccine.

• Saudi Arabia: Provided $2.8 million to the WHO in 2022 to provide logistical support for vaccine delivery in order to vaccinate ten percent of Yemenis.

• Senegal: Commits, with Institut Pasteur de Dakar (IPD), to facilitating the new $200 million Madiba (Manufacturing in Africa for Disease Immunization and Building Autonomy ) biotechnology platform, which will include production of vaccines against COVID-19 and other diseases. In support of the project, Senegal has mobilized financing of $91 million, including an EIB loan of $79 million, and has made a 3.3 Hectares site available. The project also benefits from grants from IFC, DFC, EIB, EU, and AFD, amounting to $14 million.

• Spain: Will provide EUR 100 million to support new COVID-19-related bilateral projects. Will provide USD 200 million for the purchase of 30 million vaccines for donation through COVAX and bilaterally, as needs dictate. When combined with previous donations, Spain will have pledged to donate up to 100 million vaccines, remaining as one of the largest vaccine donor worldwide.

• South Africa: Will create a national vaccination plan that prioritizes vaccinating at-risk populations, and accelerate domestic vaccination coverage, including by guaranteeing equitable access to vaccines across income groups. As an African Union Champion, South Africa has launched a youth-focused year-long vaccination campaign with the AU to increase demand among 100 million Africans. Will use innovative models to purchase oral therapeutics like Paxlovid at an "at-cost" price and support countries that have signed sub-licenses with the Medicines Patent Pool to produce Molnuvirapir, which will facilitate access to oral therapeutics for Africans. As an AU Champion, will work towards a goal of 200 million tests administered by the end of 2022, by resourcing and supporting member states to implement Africa CDC's Enhanced Surveillance Strategy, which includes community-based testing, wastewater testing, and sentinel surveillance. Will support the new global health security and pandemic preparedness fund housed at the World Bank, and will support WHO in strengthening the global health security architecture.

• Sweden: Committed its health experts to help improve international global health architecture and help advance policies on improved pandemic preparedness. Donated 10 million vaccine doses to COVAX.

• Taiwan: Pledges an additional contribution of $1.5 million to support the fight against COVID. Will continue to provide PPE and medical equipment to fight COVID worldwide, having contributed $70 million in this effort since April 2020.

• Tanzania: Will vaccinate 70% of eligible Tanzanians by fall 2022. Will launch intra-Tanzanian regional information sharing workshops for COVID-19 mitigation.

• Thailand: Will donate over 3.3 million doses of COVID-19 vaccines, worth $14.5 million, in 2022. Will continue investing in the development of COVID-19 vaccines and cooperate with global partners on vaccine testing, research and development, and production. Will continue working actively on disease prevention and health emergency preparedness in neighboring countries to better address particularly communicable and emerging diseases. Supports in principle the United States' initiative to establish the Global Health Security Financial Intermediary Fund (FIF) under the World Bank.

• United Arab Emirates: Will provide $10 million in financial contributions and $50 million in-kind assistance of equipment.

• United Kingdom: Since December, has committed £265 million [$327 million] to the global response to COVID-19 as part of the commitment to ending the acute phase of the pandemic in vulnerable countries and future pandemic preparedness, including £105 million to expand testing capacity globally and boost oxygen supplies, and £160m as part of the UK-hosted Global Pandemic Preparedness Summit to support CEPI to reduce the time to develop vaccines against new health threats - including new COVID variants - to just 100 days. The UK has spent over £2.1 billion since 2020 to help end the pandemic, address its social and economic impacts and to support global efforts to fund, and distribute vaccines fairly.

• United States: Committed an additional $200 million to the pandemic preparedness and global health security financial intermediary fund (FIF) at the World Bank in 2022, bringing the U.S. total pledge to the FIF to $450 million to date. Committed to share U.S. Government COVID-19 vaccine-related intellectual property and research tools for greater global access. Committed to rapid review of generic products for global COVID-19 response. Committed to pilot "test and treat" strategies for the most vulnerable populations in low and middle-income countries to help prevent hospitalizations and deaths from COVID-19. Committed to additional vaccination support through Global VAX. Committed to expand investments in bilateral global health security programs. Committed to expand dose donations to include boosters and pediatric doses to accelerate global vaccine coverage. Committed to improving guidance for vaccine development to enhance protection. These commitments build on previous commitments announced in 2022, including support for a financing facility for COVID-19 vaccine purchases and delivery through the U.S. International Development Finance Corporation and advancing COVID-19 vaccine research and development through the Coalition for Epidemic Preparedness Innovations.

Commitments^[2] from Non-Governmental Organizations, Private Sector, Philanthropies

In addition, we have received commitments from more than 50 organizations, including local and international non-governmental organizations, businesses, philanthropies, advocacy groups, faith-based organizations, and other members of civil society. To date, new commitments in 2022 outlined below exceed $700 million for vaccinating the world, saving lives now, and building better health security.

• Abbott: Abbott will make available to low and middle income countries (LMICs) a dedicated portion of its global manufacturing capacity for WHO EUL-approved antigen rapid diagnostic tests (Ag RDTs), amounting to a minimum of 20 million tests per month and a total of 240 million tests for an entire year, a commitment that amounts to nearly a quarter of the global goal of ensuring access to 1 billion tests in 2022 announced in September.

• Abt Associates: Commits to convening a global coalition to identify health system innovations that emerged during the COVID-19 pandemic that can be adapted and scaled to transform future health systems and Build Better Health Security. As a trusted partner of the governments of the United States, United Kingdom and Australia, Abt Associates developed tools and innovations in our work and will share them broadly. We invite other countries and partners to engage in this collaboration.

• Access to Advanced Health Institute and Immunity Bio: commit to manufacturing next-generation T-Cell vaccines for pandemic preparedness that are stable at room temperature, rapidly modifiable to address current and emergent pathogens, and provide potent, broad and durable protection in sub-Saharan Africa at the billion dose scale by 2025. Commit to bringing the latest immune-stimulating cell therapy and vaccine technology through clinical trials and centers of excellence to develop licensed vaccines and breakthrough immunotherapies that address the pandemics of infectious disease and cancer around the Globe. Committed to expend $1 billion USD over the next 5 years to produce billions of doses of vaccines, fusion proteins, and natural killer cell therapy at our million square feet of 11 plants we currently own globally.

• Africa Frontline First (AFF): Commits to raising $15M by September 2022 in the first phase of its work to build better health security. AFF is a collaborative new financing initiative led by Her Excellency Ellen Johnson Sirleaf to professionalize 200,000 community health workers across 10 African countries by 2030. This workforce will expand critical surveillance, testing, and treatment for emerging disease threats, maintain life-saving care during emergencies, and provide quality jobs, particularly for women.

• Amref Health Africa, HQ: Commits to increase access to and uptake of COVID-19 vaccines in thirty-one countries in Africa. The activities will be led across 11 projects with multiple partners to support the administration of over 4.5 million vaccine doses across 31 countries in East and Southern Africa, training over 15,000 community health workers, and facilitating access to vaccines in hard-to-reach areas. To ensure delivery of this commitment, $46,117,000 has been secured to date.

• The Bill & Melinda Gates Foundation: Commits up to $125 million to Build Better Health Security through vaccine research and development, enhanced integrated disease surveillance, workforce capacity development, and expanded access to pandemic tools in low- and middle-income countries. These new investments, which are an extension of the foundation's longstanding commitment to health equity, are aimed at ending this pandemic and ensuring the world is prepared to prevent another pandemic.

• BlackRock Foundation: Commits $5 million to ensure immediate, equitable access to Covid-19 diagnostic tools across the world, in partnership with FIND – the global alliance for diagnostics – to keep people safe, halt new variants in their tracks and address urgent clinical needs. BlackRock will support FIND to deliver on the goal of increasing the number of daily Covid-19 tests taken in low-income countries from 7.3 per 100,000 individuals to 100 per 100,000 by the end of 2022.

• Catholic Relief Services - US Conference of Catholic Bishops (CRS): Commits to work with its in-country teams to increase vaccine coverage and uptake, directly supporting COVID-19 vaccinations in 22 countries and mobilizing at-risk populations in over 100 countries. CRS will engage local stakeholders to facilitate collaboration and connect local partners with donors to advance localized funding. CRS will mobilize American Catholics to advocate for an equitable global response and will engage with peer organizations through the INGO COVID-19 Vaccine Collaborative. Commits to leveraging its network of over 1500 partners to communicate essential information to reduce COVID-19 transmission, illness and death. CRS will serve as the Global Fund C19RM lead in Republic of Congo, Guinea, Mali, Niger and Sierra Leone, leading on procurement for tests and other commodities. CRS will address the secondary impacts of COVID-19, such as education disruption, the loss of primary caregivers, fraying social cohesion, and increasing hunger and malnutrition. Commits to using its available resources to identify, finance, and fill gaps in health systems in the countries in which it operates. CRS will continue implementing activities to address vaccine hesitancy, conducting primary research to inform vaccine strategies, supporting faith-based organizations, and financing critical health workforce trainings. Further, CRS will continue to work with Ministries of Health and other health service providers to strengthen the capacity of resilient health systems.

• Clinton Health Access Initiative (CHAI): Commits to ensuring affordable and effective antiviral COVID-19 treatment is available in low- and middle-income countries. CHAI has negotiated agreements with generic suppliers to make generic Paxlovid (nirmatrelvir/ritonavir – NIR/r) available at under $25 USD per treatment course for treatment of COVID-19. Equitable access to oral antiviral medications, especially for high-risk populations, will help save lives and limit the impact of future surges.

• Coalition for Epidemic Preparedness Innovations (CEPI): Commits to helping fill the gaps in vaccine research and development that threaten to undermine progress against COVID-19, working in partnership with institutions in low- and middle-income countries. Such research, including clinical trials on "mix-and-match" and fractional dosing, will help to inform COVID-19 vaccination strategies globally. Commits to funding the development of broadly protective COVID-19 vaccines and working to enable equitable access to these globally. Will work to reduce global pandemic risk by delivering innovative R&D programs that help to develop safe, effective, globally accessible vaccines in 100 days. This includes advancing vaccines against known threats; producing a library of prototype vaccines against critical viral families; investing in vaccine manufacturing innovations; advancing enabling science programs critical to rapid vaccine development; and connecting stakeholders to enable rapid countermeasure development, effective response and equitable access.

• CORE Group: Will work with country partners to provide training on addressing vaccine misinformation through social behavioral change norms and provide evidence-based communication training and tools to increase demand and uptake for COVID-19 vaccine. CORE Group will conduct knowledge sharing events and sessions at the regional and global levels, to share innovative ideas of addressing vaccine hesitancy, share tested and translated resources, and convene civil society to improve COVID19 vaccine uptake. Will convene global stakeholders to ensure implementation strategies around health security with a One Health approach and advocate for greater representation of civil society, including people with disabilities, women and children, and under-served communities, to be included in the planning and discussions around their own health security. We commit ensuring evidence-based technical direction and collaboration around Covid-19, global health security, through an integrated multi-sectoral approach, at our October 2022 Global Health Practitioner Conference.

• COVID Collaborative: COVID-19 has now left a staggering 10.4 million children worldwide orphaned by the death of a parent or grandparent caregiver. Many of these children face abuse, violence, and institutionalization. That is why COVID Collaborative, in collaboration with Oxford University, and with support from The New York Life Foundation, commits to advocate for and catalyze country-level policies to incorporate family-based care for COVID-bereaved children into national COVID-19 response plans, focusing on high-burden countries in sub-Saharan Africa.

• Deloitte Touche Tohmatsu Limited (Deloitte): Commits up to US $3 million to make publicly available a playbook that outlines processes and protocols that enable society to provide and scale health-care support and resources, thereby helping to address COVID-19 variants and surges, in support of the goal to Build Better Health Security

• FIND: Commits to enhancing efforts for timely testing, including self-testing, in vulnerable groups, providing vital information to assess transmission in diverse populations and formulate strategies to prioritize those most at risk. These efforts will also help focus testing and treatment strategies. Commits to supporting LMIC governments in the development and roll-out of scaled up testing and test-and-treat programmes, focused on vulnerable populations and equitable global access, as well as maintaining the data gathering and reporting systems that will allow global, regional and national decision-making based on the best possible information about the state of the pandemic. Commits to identify and work with partners for the development and validation of multipathogen diagnosis and care pathways, which must include COVID-19. These new tools and diagnostic pathways will also be designed and tested to strengthen surveillance systems for both endemic and pandemic-prone pathogens, and link to the use of enhanced capacity for genomic sequencing.

• Friends of the Global Fight Against AIDS, Tuberculosis and Malaria: Commits to partner with other organizations to lead advocacy for new investments in pandemic preparedness that are grounded in human rights, integrated with health systems, and include multiple stakeholders. The organization will help mobilize global advocacy to remind donors that the US is hosting the replenishment of the Global Fund, another effective tool in building health systems and preparing for the next pandemic alongside a new pandemic preparedness fund.

• Family Health International (FHI) 360: Commits to engaging in at least 20 LMICs with governments, local organizations, and communities to build their capacity to provide COVID-19 vaccine service delivery and generate demand for COVID-19 vaccines. FHI 360 commits to documenting and sharing innovative ideas and approaches to overcoming vaccine hesitancy globally. Commits to converting technical tools and resources to global goods and taking proactive efforts to make these tools available to LMICs and promote their use for strengthening COVID-19 response programs. FHI 360 commits to enhance health workers' capacity to deliver oxygen to patients in clinical settings and improve oxygen ecosystems in at least 25 LMICs, to promote equitable access to the highest quality clinical services possible. Commits to support at least 15 LMICs to achieve their health security goals and achieving International Health Regulations (IHR) targets and achieve Sustainable Development Goals. FHI 360 commits to developing new tools and technologies to support these efforts.

• Global Health Council (GHC): Commits to continued advocacy with U.S. congressional leaders to accelerate financing for COVID-19 vaccination campaigns. Global COVID-19 supplemental funding is urgently needed to support these national and sub-national campaigns to make progress toward the 70% target, prioritizing groups like frontline health workers, the elderly, and the immunocompromised. GHC will continue to bolster commitments amongst stakeholders within multilateral organizations and ensure these bodies are sustainably-resourced and well-equipped to address the world's most pressing health needs.

• Global Health Technologies Coalition (GHTC): Committed to amplify evidence of gaps in upstream vaccine research and development (R&D) for the COVID-19 response and work to ensure political support and additional resources to support R&D of next-generation vaccines designed to better reach the last mile and address emerging variants and for strengthening regional research and manufacturing capacities. This includes expanding multisector support for clinical research, strengthening regulatory pathways, and mobilizing sustainable financing for regional manufacturing hubs. Will hold public- and private-sector stakeholders accountable to unlocking funding and advancing research to expand the pipeline of affordable, easy-to-deploy diagnostics and therapeutics, particularly for use in low-resource settings. Will galvanize partners to push for more efficient regulatory pathways for novel COVID-19 technologies; bolstered testing, surveillance, genomic sequencing, and data sharing to better detect and monitor emerging variants; and strengthened regional manufacturing capacities. Supports the creation of a new pandemic preparedness fund and will leverage its network to highlight how the fund should be utilized to bolster country and regional pandemic research and development (R&D) capacities. GHTC is also supporting the Global Health Security Agenda R&D Task Force to develop a tool that enables countries to assess their R&D preparedness capabilities with the goal of aligning emerging financing with articulated R&D gaps.

• Google.org: Donating an additional $150 million in Search ads to the World Health Organization, Gavi, government agencies, and nonprofits to ensure users searching on COVID-19 related topics such as vaccines, testing, or economic recovery initiatives are connected with credible sources. This brings Google.org's total in-kind global commitment to COVID-19 recovery to over $1 billion."

• HelpAge USA: Commits to promoting the dignity, wellbeing, and voice of older people. We are working with partners at global, regional, national, and local levels to develop and implement inclusive community engagement and advocacy strategies that effectively support COVID-19 vaccine access and uptake among older people and achieve global vaccine equity. Our organization's goal aligns with the summit's objective to vaccinate the world.

• Henry Schein, Inc.: Henry Schein commits to working in partnership with the WHO to develop platforms for supply chain data collection to strengthen the resilience of the global healthcare supply chain. This work represents an expansion of the Pandemic Supply Chain Network (PSCN), a public-private partnership founded in 2015. Henry Schein serves as private sector lead of the PSCN, with more than 60 companies participating together with the WHO and other multilaterals. Henry Schein is contributing its core competencies to support this effort, and a cash donation of $25,000.

• The Hygiene and Behaviour Change Coalition 2 (HBCC2): Will encourage vaccine uptake and combat vaccine hesitancy alongside continued hygiene messaging, using its hygiene and behaviour change platform to incorporate vaccine confidence messaging where vaccines are available. The coalition will reach millions through incorporating vaccine messages into public campaigns and programmes, and create digital tools that support people with information on COVID-19 vaccines, including where it is available and how to access it (where applicable). Will help millions of people by supporting measures to reduce transmission of COVID-19 in 18 countries across Africa and Asia by provision of critical WASH products and services as hygiene remains the first line of defence against the virus until vaccines reach all. The coalition will provide communities with hygiene advice and training, products, and handwashing facilities in institutions such as schools, health centres and public places. Will work with national governments and institutions to strengthen local capacity and build resilience of health systems and communities against new COVID-19 variants and future pandemics. The hygiene vulnerabilities and inequalities the pandemic has exposed must be eradicated if we are to defeat the virus and improve health security for all. HBCC2 will advocate for increased investment in hygiene and pandemic preparedness at national and global level.

• International Rescue Committee (IRC): Commits to extending the capacity of governments to deliver Covid-19 vaccines in humanitarian settings as soon as delivery funds and doses become available to us. Based on our current infrastructure and capacity, we can deliver 32 million doses, fully vaccinating 16 million people. With $160 million dollars and sufficient doses, we could reach nearly all eligible people in the fragile and conflict affected settings where we work across 30 countries.

• IPG Health/McCANN HEALTH: Committed to working with countries to develop more effective ways to increase COVID-19 vaccine uptake.

• Living Goods: Commits to supporting community health workers (CHWs) to ensure high levels of uptake of COVID-19 vaccines and to combat COVID-19 vaccine hesitancy. Living Goods commits to supporting government operations for widespread COVID-19 vaccine rollout to the individuals in the rural communities served by Living Goods-supported CHWs. Finally, Living Goods commits to encouraging uptake of COVID-19 vaccination among frontline health workers and other high-risk populations. Commits to working in partnership with governments to train all staff and community health workers (CHWs) we support in COVID-19 prevention, early case detection, reporting procedures, and personal safety measures. Living Goods commits to supporting CHWs to educate communities on prevention, testing and where to receive care. Living Goods commits to using digital tools to support CHWs to conduct COVID-19 case screenings and connect CHWs with disease surveillance networks. Commits to partnerships with the governments of Kenya, Uganda, Burkina Faso, and others to build resilient community health systems that can withstand shocks. This includes supporting governments to strengthen digital tools that enable the delivery of health services and ensure pandemic preparedness. Over the next five years, Living Goods commits to supporting 32,000 CHWs and their supervisors to reach 18 million people across five countries with quality care.

• Management Sciences for Health: Is costing vaccine delivery to the last mile so that countries, multilateral institutions, and donors can prepare to effectively deliver critical COVID-19 vaccines and achieve the goal of vaccinating the world. This work will help countries better allocate financial resources through evidence-based and sustainable strategies. To date, the organization has supported the vaccination of almost 17 million people across several countries. Management Sciences for Health is committed to Saving Lives Now by continuing to provide access to critical health services, medicines, and other therapeutics across countries, including in fragile and conflict-affected states. The organization continues to focus on strengthening pharmaceutical-sector governance, national public health institutions, regulatory and information systems, infection prevention and control measures, response coordination mechanisms, and emergency supply chains for COVID-19 commodities across governments, the private sector and civil society. Management Sciences for Health is announcing new investments in learning critical lessons from the COVID-19 response by convening a global workshop to examine critical gaps in health security and develop impactful, responsive, and essential recommendations for better pandemic preparedness. MSH is committed to working with country policymakers and government officials to ensure the necessary national policies are in place so that countries are better prepared for future threats through a multihazards approach to pandemic preparedness.

• MedAccess: Commits to provide a $100 million guarantee to accelerate access to COVID-19 vaccines through the COVAX cost-sharing mechanism. The guarantee is part of a $200 million risk sharing facility, with the Open Society Foundations, that will help COVAX respond to country demand for additional doses to meet national vaccination targets.

• Mastercard Foundation: Mastercard Foundation is deploying USD $200 million in partnership with a collaborative of seven African higher education institutions to strengthen the resilience of public health systems in Africa and enabling them to contribute to economic development, and prosperity. To do so, this initiative will train 30,000 front-line health providers and policy shapers and is projected to create 20,000 health sectors jobs; and to enable 2,000 health ventures to improve and expand primary health services and products in the next 10 years.

• Merck & Co., Inc. (Merck): Committed to make two million patient courses of its investigational oral antiviral COVID-19 medicine, LAGEVRIO (molnupiravir), available to USAID at Merck's best access price to increase access in lower-income countries. This builds on previous efforts, including an agreement with UNICEF to supply up to 3 million courses of LAGEVRIO and voluntary licenses to generic manufacturers and the Medicines Patent Pool facilitating access in over 100 low and middle income countries. Committed to provide $5 million annually in 2022-2024 to support efforts to understand how to build vaccine confidence and reach underserved populations through use of social media. This builds on Merck's earlier funding to help establish The Vaccine Confidence Fund to support research exploring how online communications can influence offline health behavior and build vaccination confidence, and its related announcement with multi-sector stakeholders of the Alliance for Advancing Health Online.

• Nuclear Threat Initiative (NTI): Nuclear Threat Initiative (NTI): Commits to support the Financial Intermediary Fund by using the Global Health Security Index as a tool to inform pandemic preparedness needs-so resources can be allocated to countries most in need and to address the most significant gaps. NTI also commits to contribute $35,000 to the Fund once established-reflecting our view that catalytic funding is needed to guard against current and future biological threats.

• Nursing Now Challenge: Commits to engaging its network to build advocacy skillsets for early-career nurses and midwives to deepen their storytelling skills and to launch local, regional and global efforts to vaccinate the world. The NNC network of immunization advocacy champions will be led by early-career nurses and midwives. They will lead their own vaccine advocacy campaigns and will deliver their voices to at least three global policy forums and quarterly online events.

• Open Society Foundations: Open Society Foundation's impact investment arm, the Soros Economic Development Fund (SEDF), commits to provide a $100 million procurement guarantee designed to strengthen COVAX's capacity to increase the distribution of COVID-19 vaccines to low- and middle-income countries. Together with an additional $100m guarantee from MedAccess, the guarantees would free up an additional $200m in donor funds, and position COVAX to deploy an additional 190 million vaccine dosages to low- and middle-income countries globally in 2022.

• Osprey Foundation: Committing $4,000,000 to faith-based organizations that can positively influence COVID-19 vaccine access and uptake in sub-Saharan Africa. Commits to increase vaccine demand in several sub-Saharan African countries by supporting faith leaders and their networks to overcome disinformation and address the root causes of vaccine hesitancy for their communities in both digital and non-digital realms. Concurrently, Osprey Foundation will fund faith-based interventions to improve the delivery of COVID-19 vaccines by strengthening the core of last-mile vaccine infrastructure, improving vaccine readiness, and supporting effective vaccine rollout initiatives.

• Pandemic Action Network: Commits to press governments, multilateral agencies, and donors to galvanize the necessary investments, coordination, and incentives to support delivery of accelerated, robust, and equitable global vaccination plans to achieve equitable global immunization levels. In support of this and all Summit goals, Pandemic Action Network commits to mobilize at least 100 new partners, and Network partners commit to invest at least US$175 million by the end of 2022. Commits to support efforts to drive forward a dynamic global test-to-treat strategy, increase transparency on pricing and supply of tools to fight COVID-19, and advocate to prioritize access to testing, timely reporting, and treatments. The Network also commits to and to create a steady drumbeat of advocacy, coordination, and civic engagement and hold partners accountable for their commitments. In 2022, commits to work with the World Bank, WHO, governments, and other stakeholders to design and launch a dedicated new global fund for pandemic preparedness; mobilize significant new political and financial commitments for the fund; promote cross-country, cross-regional cooperation, and sharing best practices and lessons learned to inform more effective and equitable preparedness and response plans and implementation, to be ready either for the next COVID surge or next potential pandemic.

• PATH: Commits to supporting COVID vaccination campaigns by providing training, mentorship and supervision to health workers tasked with vaccination and to deploying and scaling digital tools to track vaccination and generate demand through targeted social media campaigns. This includes a $5 million investment to reach an estimated 20 million vaccine-hesitant individuals in two years. Additionally, PATH will support the development of a new affordable COVID-19 vaccine that could be manufactured in Brazil, Thailand and Vietnam. Commits to working with stakeholders to improve oxygen delivery in 10 countries. PATH will work with local partners to build their diagnostics capacities and support the advancement of more affordable and reliable COVID diagnostics in LMICs. PATH will stand up interoperable digital systems in four countries to provide the country governments with the information they need to identify and manage outbreaks vaccination coverage, manage vaccine supplies, and track vaccination records. Commits to leveraging our technical expertise to equip world leaders with the information they need to design a better architecture for global health security. PATH commits to advocating for the funding needed to establish the new global health security and pandemic preparedness fund and holding leaders accountable for other commitments made during the 2nd COVID-19 Summit.

• PAX sapiens: Will work with engaged civil society, philanthropic, government, and private sector actors to identify and promote sustainable funding sources for pandemic prevention, new approaches to information sharing, institutional design, and standards for data collection and sharing, and to encourage new donors to support pandemic prevention. PAX's work will include grantmaking through the previously announced commitment of $200 million, convening and engagement with other organizations, and developing new information for effective prevention.

• PerkinElmer: Commits to saving lives now by making COVID-19 tests available to all low- and middle-income countries for under $5 per test based on volume commitment and supply chain feasibility. PerkinElmer knows that detecting COVID-19 is still a public health challenge in many places and believes this will enable critical access to diagnostics. PerkinElmer remains dedicated to continuing to develop accessible diagnostic solutions to address the global public health challenges created by the COVID-19 pandemic.

• Pfizer Inc.: Will work to solve concrete challenges to vaccine distribution: working with partners, including UPS, to enable extended use of its shippers to deliver 9.3 million doses to regional vaccination centers in 36 states in Nigeria; expanding its partnership with drone delivery service Zipline to enable transportation of more 380,000 mRNA vaccines on 1,485 drone flights to remote areas; and completing studies to support the extension of transportation time to 48 hours at 2-8 degrees. Pfizer's COVID-19 oral treatment could significantly change the COVID-19 treatment paradigm, potentially reducing illness severity, hospitalization rates and deaths among a broad population of patients, subject to regulatory authorization or approval. Working with partners such as UNICEF, Pfizer will supply nirmatrelvir [PF-07321332] tablets and ritonavir tablets to countries in need, including emerging economies in Sub-Saharan Africa, Asia, and the Americas. This agreement is part of Pfizer's comprehensive strategy to work toward worldwide equitable access.

• Platform for ACT-A Civil Society & Community Representatives (co-hosted by WACI Health, Global Fund Advocates Network (GFAN) and STOPAIDS): Will advocate for support of the TRIPS waiver and sharing of vaccine equipment and doses with COVAX and countries. Will advocate for and coordinate community CSO input on a test and treat strategy. Will mobilise support to fully fund ACT-A, advocating for robust health system perspectives, supporting greater community representation in ACT-A and future mechanisms.

• Private Sector Roundtable on Global Health Security (PSRT): The Private Sector Roundtable on Global Health Security (PSRT) - a cross-industry coalition of companies committed to leveraging private sector expertise to strengthen health security - commits to expand efforts to build regional/country capacity in pandemic prevention, preparedness and response. We will seek to partner with a regional institution and three low-middle-income countries in that region to provide a suite of tools, trainings and expert guidance over the next three years to Build Better Health Security.

• Rotary International: Commits to providing access to our public health infrastructure and network built to facilitate polio eradication and provide free health services to vaccinate the world. Rotary Family Health Days and National Immunization Day campaigns are available to accelerate vaccine coverage in multiple regions with at-risk populations in high-risk countries. With Rotary's 1.4 million members worldwide, and over 55,000 African members, our health infrastructure, and relationships with local and national government health departments remain active. Rotary can quickly mobilize, as strategy, structure, accountability, and funding become available.

• The Rockefeller Foundation: The Rockefeller Foundation's Global Vaccination Initiative commits USD 55 million to support country-led efforts to fully vaccinate 90% of the most at-risk populations in Africa, Asia, Latin America, and the Caribbean. Funding will support programs to increase vaccine demand - access, trust, and information - while leveraging data from trusted, credible sources to strengthen health systems to meet the needs of the most vulnerable.

• Sabin Vaccine Institute: Commits $9 million through its Global Immunization program in 2022 to better understand and address vaccine delivery, acceptance and demand barriers in LMICs; bolster collaboration among immunization professionals; foster action to address barriers in universal vaccination development; and better apply epidemiology to maximize vaccine rollout effectiveness. Sabin commits to fostering the action of 3,000+ close-to-community professionals delivering vaccinations in LMICs - including health workers, program managers, researchers and journalists.

• Seed Global Health: Research estimates that for every $1 allocated to vaccine production, $5 is needed for delivery, with majority cost being associated with health worker training, support, and protection. Establishing integrated health worker networks from the last mile to the facility is critical to enabling access to vaccinations. . Seed Global Health commits to partnering with governments to train and deploy the health workers required to put shots in arms while supporting counter-misinformation campaigns to reduce vaccine hesitancy. Health workers deliver every element of pandemic response and preparedness. Commits to scale our direct work in training and care to sustain essential services to an additional 3 million people; to protect education to strengthen the pipeline of health workers; to respond to emergencies on the frontlines, modeling new methodologies of diagnosis and care; and to align and mobilize the political commitment and resources to support health workers and save more lives. Health workers are the backbone of resilient health systems and pathway to economic recovery and global health security. Commits to mobilize a social contract for health workers, to galvanize action beyond applause. Centered on core principles that provide the evidence-based rationale, framework and accountability, this compact will mobilize and align investments, policies, and programming around long- term country-led planning, to scale-up and protect fit-for-purpose health workforces in service to the world.

• The Task Force for Global Health: Will partner with countries to strengthen immunization programs and field epidemiology training. Through Hepatitis, Polio and Neglected Tropical Diseases programs, we'll support COVID-19 efforts for the most vulnerable. We'll distribute medical supplies/equipment and support public health worker mental health and resilience. We'll convene thought leaders to envision building upon COVID-related investments for sustainable systems. We'll advance the scientific understanding of rare adverse events after COVID-19 vaccinations, advancing evidence-based decision-making.

• Thermo Fisher Scientific: In partnership with Afrigen Biologics and Labotec, we are providing cutting-edge technology and personalized capacity building to enable production of the first locally designed and constructed COVID vaccine for Africa. Our support for this WHO-coordinated, end-to-end, sustainable mRNA vaccine production hub includes facility design and bacteria cultivation tools to support DNA plasmid creation, as well as investing in time and expertise to transfer technical knowledge and support so scientists and healthcare leaders can create their own future. As part of our Mission to enable our customers to make the world healthier, cleaner and safer, we have a responsibility to provide access to COVID-19 diagnostic solutions that reach every population, community and individual, regardless of geography or socioeconomic circumstance. We will continue to provide low price, high-quality diagnostic solutions to Governments, United Nations and other global partners because testing is the cornerstone of a continuum of care and treatment of COVID-19 globally. We recognize the importance of building upon lessons learned from the COVID-19 pandemic and will continue to collaborate with Governments, the United Nations and other global partners to create resilient systems to better prevent, detect and respond to the next emerging pathogen. This includes helping to create federated, open pathogen surveillance systems, designing and funding knowledge transfer programs to enable the next generation of scientists in LMICs, and investing in local manufacturing models.

• United Nations Foundation: The United Nations Foundation supports Building Better Health Security through encouraging high ambition, sustained attention, and diverse coalitions to strengthen multilateral capacities for preparedness and response. This includes convening and engaging partners to support Geneva-based processes; supporting solutions for incremental financing, including a Financial Intermediary Fund housed at the World Bank; and engaging Member States in New York and capitals to diversify and broaden a high ambition coalition for this agenda.

• UPS Foundation: Commits to the pro-bono delivery of COVID-19 vaccines to countries below the average vaccination rate for Africa. In 2022, the UPS Foundation also plans to deliver 2 million doses to Cameroon, up to 3 million to Ethiopia, and up to 4 million to Zambia. The UPS Foundation commits to expanding upon its existing Ghana medical drone network in 2022 to provide the delivery of critically needed supplies and expand access to quality health care. In-country transportation has been committed for 1 million doses to new Zipline drone distribution centers in Nigeria and Kenya. In Malawi, the UPS Foundation is funding in-country drone delivery provided by Swoop Aero and Village Reach with plans to reach 3 million people. In partnership with UNICEF, the UPS Foundation is funding 'Ultra Cold Vaccine Training' in Malawi, Nigeria, Ethiopia, and Kenya.

• UPS Healthcare: Commits to delivering 5.9 million vaccines to Nigeria in addition to the 9.3 million previously delivered. The shipment is funded through UNICEF and USAID, and coordinated with technical expertise from UPS and donated ultra-cold chain equipment. To date, UPS Healthcare has delivered more than 1.4 billion COVD-19 vaccine doses to over 110 countries.

• Wellcome Trust: As a founding partner of the Coalition for Epidemic Preparedness and Innovations we committed $150M to CEPI this year, as part of Wellcome's commitment to spend £16B over the next ten years on science to improve health. This includes funding for Infectious Disease and Pandemic Preparedness, to help buildnetworks to detect outbreaks before they escalate, to trainpublic health professionals and enhance capacity globally, and expand Research and Development of countermeasures. Wellcome also supports mobilising additional funds to prevent future pandemics, and is providing £10 million in seed funding toward establishing the pandemic preparedness and global health security Financial Intermediary Fund at the World Bank, signalling our early philanthropic commitment to working in partnership with others in the fund. We applaud this Summit which comes at a critical moment. We believe these collective commitments will contribute to ensuring equitable health security for all and the world has the knowledge and networks in place to prevent and respond to emerging threats whilst remaining committed to long standing endemic health issues of importance to communities.

• Women in Global Health: Commits to advocate for: Equal leadership representation in global health governance, including pandemic decision making and advisory bodies; a new social contract for women health workers with safe, decent and equally paid work. This includes protection from harm and personal protective equipment designed for women's bodies; and addressing the gender dimensions and impacts of pandemic policies and programmes, using sex disaggregated data.

^[1] All commitments made in 2022 are counted toward the goals of the 2^nd Global COVID-19 Summit. Of these, approximately $2.5 billion were raised in new funds, not yet announced.

^[2] All commitments made in 2022 are counted toward the 2^nd Global COVID-19 Summit. Of these, approximately $700 million was raised in new funds, not yet announced.